Teriparatide anabolic therapy as potential treatment of type II dens non-union fractures

Enrico Pola*, Virginia Pambianco, Debora Colangelo, Virginia M. Formica, Giovanni Autore, Luigi A. Nasto, Luigi Aurelio Nasto

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

4 Citazioni (Scopus)

Abstract

Odontoid fractures account for 5% to 15% of all cervical spine injuries and 1% to 2% of all spine fractures. Type II fractures are the most common fracture pattern in elderly patients. Treatment (rigid and non-rigid immobilization, anterior screw fixation of the odontoid and posterior C1-C2 fusion) remains controversial and represents a unique challenge for the treating surgeon. The aims of treatment in the elderly is to quickly restore pre-injury function while decreasing morbidity and mortality associated with inactivity, immobilization with rigid collar and prolonged hospitalization. Conservative treatment of type II odontoid fractures is associated with relatively high rates of non-union and in a few cases delayed instability. Options for treatment of symptomatic non-unions include surgical fixation or prolonged rigid immobilization. In this report we present the case of a 73-year-old woman with post-traumatic odontoid nonunion successfully treated with Teriparatide systemic anabolic therapy. Complete fusion and resolution of the symptoms was achieved 12 wk after the onset of the treatment. Several animal and clinical studies have confirmed the potential role of Teriparatide in enhancing fracture healing. Our case suggests that Teriparatide may have a role in improving fusion rates of C2 fractures in elderly patients.
Lingua originaleEnglish
pagine (da-a)82-86
Numero di pagine5
RivistaWORLD JOURNAL OF ORTHOPEDICS
Volume8
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Anabolic therapy
  • Fracture healing
  • Non-union
  • Orthopedics and Sports Medicine
  • Teriparatide
  • Type II odontoid fractures

Fingerprint

Entra nei temi di ricerca di 'Teriparatide anabolic therapy as potential treatment of type II dens non-union fractures'. Insieme formano una fingerprint unica.

Cita questo